Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001538-16Phase 2Completed
Phase 2, open-label, single-arm trial of calcipotriol + betamethasone in psoriasis, sponsored by LEO Pharma. Primary endpoint: Adverse drug reactions (ADRs). Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001538-16.